Kane Biotech Inc (KNE)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Kane Biotech Inc (KNE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010917
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develops human health products, animal health products, medical device coating and hard surface disinfectant. Kane Biotech also develops shampoos and skin care formulations for human skin infections including seborrheic dermatitis. The company caters its products to industrial, human and animal healthcare industries. It works in partnership with academic institutions to develop new technologies. Kane Biotech is headquartered in Winnipeg, Manitoba, Canada.

Kane Biotech Inc (KNE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Kane Biotech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kane Biotech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kane Biotech Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Kane Biotech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kane Biotech Inc, Medical Equipment, Deal Details 10
Partnerships 10
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 10
Equity Offering 11
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 11
Kane Biotech Raises USD3 Million in Private Placement of Units 12
Kane Biotech Raises USD0.5 Million in First Tranche of Private Placement of Shares 13
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 14
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 15
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 16
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 17
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 19
Debt Offering 20
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 20
Kane Biotech Inc – Key Competitors 21
Kane Biotech Inc – Key Employees 22
Kane Biotech Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Nov 14, 2017: Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options 24
Aug 16, 2017: Kane Biotech – Q2 2017 Financial Results 25
May 17, 2017: Kane Biotech – Q1 2017 Financial Reports 26
Corporate Communications 27
Sep 05, 2017: Kane Biotech Announces New Chief Financial Officer 27
Jun 05, 2016: Kane Biotech Announces Board Members 28
Jan 05, 2016: Kane Biotech appoints new CFO and announces addition of Commercialization Team Resources, Sales Representation Agreement for U.S. Market Expansion, and Grant of Options 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Kane Biotech Inc, Medical Equipment, Key Facts, 2016 2
Kane Biotech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Kane Biotech Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Kane Biotech Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Kane Biotech Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Kane Biotech Inc, Deals By Market, 2011 to YTD 2017 8
Kane Biotech Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Kane Biotech Extends R&D Agreement with U.S. Army Institute of Surgical Research 10
Kane Biotech Raises Funds through Second Tranche of Private Placement of Units 11
Kane Biotech Raises USD3 Million in Private Placement of Units 12
Kane Biotech Raises USD0.5 Million in First Tranche of Private Placement of Shares 13
Kane Biotech Raises USD1.8 Million in Rights Offering of Shares 14
Kane Biotech to Raise up to USD2.8 Million in Private Placement of Units 15
Kane Biotech Raises USD0.5 Million in Private Placement of Shares upon Exercise of Warrants 16
Kane Biotech Raises USD0.04 Million in Second Tranche of Private Placement of Units 17
Kane Biotech Completes Private Placement Of Units For US$1.5 Million 19
Kane Biotech Amends Terms of Private Placement of Convertible Note and Warrants 20
Kane Biotech Inc, Key Competitors 21
Kane Biotech Inc, Key Employees 22

★海外企業調査レポート[Kane Biotech Inc (KNE)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Autobahn Tank & Rast Holding GmbH:企業の戦略・SWOT・財務情報
    Autobahn Tank & Rast Holding GmbH - Strategy, SWOT and Corporate Finance Report Summary Autobahn Tank & Rast Holding GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • University of Pittsburgh Medical Center:企業の戦略的SWOT分析
    University of Pittsburgh Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Celon Pharma SA (CLN)-製薬・医療分野:企業M&A・提携分析
    Summary Celon Pharma SA (Celon Pharma) is an integrated pharmaceutical company which carries out research and develops novel therapies. Its product portfolio includes Aromek, Salmex, Valzek, Lazivir, Bosentan Celon, Donepex and Ketrel. The company primarily focuses on the development of pharmaceutic …
  • ATCC:製薬・医療:M&Aディール及び事業提携情報
    Summary ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other ma …
  • Sumitomo Mitsui Construction Co Ltd (1821):企業の財務・戦略的SWOT分析
    Sumitomo Mitsui Construction Co Ltd (1821) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Evraz Plc:企業のM&A・事業提携・投資動向
    Evraz Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Evraz Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Alchemia Ltd (ACL):企業の財務・戦略的SWOT分析
    Alchemia Ltd (ACL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Yokogawa Electric Corporation:戦略・SWOT・企業財務分析
    Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report Summary Yokogawa Electric Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Atlantia SpA (ATL):企業の財務・戦略的SWOT分析
    Atlantia SpA (ATL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Juvenile Diabetes Research Foundation-医療機器分野:企業M&A・提携分析
    Summary Juvenile Diabetes Research Foundation (JDRF) is a research organization that offers funding services for type one diabetes. The organization conducts clinical trials for curing, preventing and treating for type one diabetes and its complications; and researching new drugs for patients to man …
  • Bruce Power LP:企業の戦略的SWOT分析
    Bruce Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Orcas Power & Light Cooperative:企業の戦略的SWOT分析
    Orcas Power & Light Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Orion Corp (ORNBV):製薬・医療:M&Aディール及び事業提携情報
    Summary Orion Corp (Orion) is a developer of pharmaceuticals and diagnostic tests. The company develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients (APIs) and diagnostic tests. It focuses on developing pharmaceutical products for central nervous …
  • Paragon Offshore Plc:石油・ガス:M&Aディール及び事業提携情報
    Summary Paragon Offshore Plc (Paragon Offshore) is an oil and gas company that offers offshore drilling rigs. The company provides contract drilling, maintenance and fleet management services. It operates through a fleet of rigs including Jackup rigs, Drillships and semi submersible rigs. Paragon Of …
  • Regulus Therapeutics Inc (RGLS):医療機器:M&Aディール及び事業提携情報
    Summary Regulus Therapeutics Inc (Regulus Therapeutics) is a biopharmaceutical company that discovers and develops microRNA based therapeutics. The company provides single stranded oligonucleotides, which are chemically synthesized chains of nucleotides that are mirror images of specific target micr …
  • Tethys Oil AB (TETY):企業の財務・戦略的SWOT分析
    Summary Tethys Oil AB (Tethys Oil) is an upstream oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company holds onshore exploration licences in Lithuania and France. Tethys Oil holds Gargzdai license, Rietavas license and Raseiniai license …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Berkshire Hills Bancorp, Inc.:企業のM&A・事業提携・投資動向
    Berkshire Hills Bancorp, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Berkshire Hills Bancorp, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Rosseti (RSTI):電力:M&Aディール及び事業提携情報
    Summary Rosseti is an electricity grid company. It operates energy networks, and transmits and distributes electricity in Russia. Rosseti operates through a portfolio of affiliated and dependent companies including interregional and regional distribution grid companies. Through joint projects and ot …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆